Purchase Order 75F40120P00091
Award Date 2/28/20
Potential Completion Date 3/12/21
Potential Value $96K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Dauphin Island, AL 36528, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $114,681.00 contract is for the delivery of a MiSeq System, a high-throughput next-generation DNA sequencing platform used to support life science research, applied markets, and molecular diagnostics. This award does not have a set-aside designation. Illumina has a history of providing...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents, to provide a MiSEQ SYSTEM. The $152,792.00 contract has no set-aside designation. Illumina has previously been awarded prime contracts by other federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Veterans...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the delivery of 3 Illumina MiSeq sequencing systems. The $284,971.50 contract has an April 30, 2019 completion date and does not use any set-aside provisions. Illumina has a history of providing sequencing equipment and consumables to support genomic research and diagnostics at various federal...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and related products, for the provision of a MiSeq sequencing instrument and a one-year preventative maintenance agreement. The total potential value of this contract is $109,857.00. Illumina has a history of providing sequencing systems and services to support genomic research and diagnostics across various federal...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $87,870.00 contract is for the provision of a MiSeq DNA sequencing system and related consumables. The award has no set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $75,448 contract provides a MiSeq support plan to maximize the performance and ensure continued operation of the MiSeq sequencing system. The sequencing data generated by the MiSeq will be used to evaluate the genetic consistency and safety of viral vaccines, as well as genetic characterization of...
- The Department of Health and Human Services Food and Drug Administration awarded a $136,975.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for MiSeq sequencing service agreements covering four instruments, with a performance period ending on March 8, 2023. Illumina has previously received prime federal awards from agencies like the National Institutes of Health and Department of Veterans...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the provision of MiSeq sequencing systems and reagent kits, with a ceiling value of $291,742.95 and a completion date of September 13, 2017. The contract was not set aside for any specific business category. Illumina has previously been awarded prime federal contracts and subcontracts by agencies...
- This federal contract award was issued by the Office of the Chief Operating Officer (a civilian agency) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $95,931.00, is for the provision of the MiSeq System, an integrated system for automated generation of DNA clonal clusters. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received prime federal contract...
- The Food and Drug Administration awarded a $996,000 firm fixed-price delivery order to Illumina, Inc. for a MiSeq Sequencer and associated reagents on September 15, 2014, with an ultimate completion date of September 13, 2017. The award was issued to the San Diego-based biotechnology company without set-aside designation, reflecting Illumina's specialized position as the primary provider of next-generation DNA and RNA sequencing technologies to federal agencies. The delivery order procures...